Concepedia
Statistics
Publications
18
Citations
1.1K
H-Index
15
Active since
1983
Affiliations
University of Liverpool(Current)
Molecular Discovery (United Kingdom)
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (United States)
Ashwell Museum
Roderick A. Porter is an author at University of Liverpool specializing in pharmacology, medicinal chemistry, and medicine.
Publications per year
1983–2023
A selective orexin-1 receptor antagonist reduces food consumption in male and female rats
Andrea Haynes, Brian A. Jackson, Helen Chapman et al. · Regulatory Peptides · 2000 · 341 citations
Life Sciences, Animal Sciences, Endocrinology +6
1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor
Roderick A. Porter, Wai N. Chan, Steven Coulton et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 166 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +10
Structure–activity analysis of truncated orexin-A analogues at the orexin-1 receptor
John G. Darker, Roderick A. Porter, Drake S. Eggleston et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 69 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats
Yasuyuki Ishii, John E. Blundell, Jason C. G. Halford et al. · Physiology & Behavior · 2004 · 67 citations
Medicine, Neuroscience, Pharmacology +12
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
David Harrison, Andy Billinton, Mark G. Bock et al. · Journal of Medicinal Chemistry · 2023 · 65 citations · Full text
Life Sciences, Neurology, Pharmacology +17
1–5 of 18